{"id":"iv-n-acetylcysteine","safety":{"commonSideEffects":[{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Vomiting"},{"rate":null,"effect":"Flushing"},{"rate":null,"effect":"Rash"},{"rate":null,"effect":"Anaphylactoid reactions"}]},"_chembl":{"chemblId":"CHEMBL600","moleculeType":"Small molecule","molecularWeight":"163.20"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"N-acetylcysteine (NAC) is a prodrug that is rapidly deacetylated to cysteine, which serves as a precursor for glutathione synthesis. By increasing intracellular glutathione levels, NAC enhances antioxidant capacity and reduces reactive oxygen species (ROS). Additionally, NAC directly scavenges free radicals and modulates inflammatory pathways, making it useful in conditions characterized by oxidative stress and tissue damage.","oneSentence":"IV N-acetylcysteine replenishes intracellular glutathione and acts as a free radical scavenger to reduce oxidative stress and inflammation.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:17:26.543Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acetaminophen (paracetamol) overdose"},{"name":"Acute respiratory distress syndrome (ARDS)"},{"name":"Chronic obstructive pulmonary disease (COPD) exacerbations"}]},"trialDetails":[{"nctId":"NCT06650384","phase":"PHASE2, PHASE3","title":"Efficacy and Safety of N-Acetylcysteine Versus Alpha-Lipoic Acid in Colistin-Induced Nephrotoxicity","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2024-11-01","conditions":"Nephrotoxicity","enrollment":180},{"nctId":"NCT07391163","phase":"NA","title":"Protective Effect of N-acetylcysteine on Oxaliplatin-Induced Neuropathy in Colorectal Cancer","status":"COMPLETED","sponsor":"Tanta University","startDate":"2024-01-01","conditions":"Colorectal Cancer","enrollment":46},{"nctId":"NCT07387666","phase":"EARLY_PHASE1","title":"Imaging Acetadote Metabolism in Glioblastoma","status":"NOT_YET_RECRUITING","sponsor":"University of Texas Southwestern Medical Center","startDate":"2026-07-01","conditions":"Glioblastoma, GBM","enrollment":10},{"nctId":"NCT07293884","phase":"NA","title":"N- Acetylcysteine in Airway Clearance in Broncheictasis","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2025-12","conditions":"Broncheictasis","enrollment":70},{"nctId":"NCT02445651","phase":"NA","title":"Physiological Effects of Nutritional Support in Patients With Parkinson's Disease","status":"COMPLETED","sponsor":"Thomas Jefferson University","startDate":"2014-03","conditions":"Parkinson Disease, Idiopathic Parkinson Disease","enrollment":51},{"nctId":"NCT04374461","phase":"PHASE2","title":"A Study of N-acetylcysteine in Patients With COVID-19 Infection","status":"ACTIVE_NOT_RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2020-05-01","conditions":"Covid-19","enrollment":48},{"nctId":"NCT07229456","phase":"PHASE3","title":"Evaluation of the Role of N Acetyl Cysteine and Vitamin D in Improving Outcomes After Corrosive Ingestion","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ain Shams University","startDate":"2024-10-01","conditions":"Corrosive Injury","enrollment":80},{"nctId":"NCT01467466","phase":"PHASE3","title":"Prevention of Serious Adverse Events Following Angiography","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2013-10-07","conditions":"Acute Renal Failure, Kidney Disease, Coronary Artery Disease","enrollment":5177},{"nctId":"NCT06039566","phase":"PHASE3","title":"NAC vs Placebo on Opioid Use for Hysterectomy","status":"RECRUITING","sponsor":"Medical University of South Carolina","startDate":"2023-11-30","conditions":"Hysterectomy","enrollment":240},{"nctId":"NCT03032601","phase":"NA","title":"Physiological Effects of N-Acetyl Cysteine in Patients With Multiple Sclerosis","status":"ENROLLING_BY_INVITATION","sponsor":"Thomas Jefferson University","startDate":"2017-01-05","conditions":"Multiple Sclerosis","enrollment":55},{"nctId":"NCT07097727","phase":"PHASE1","title":"Evaluation of the Role of Acetyl Cysteine in Ventilator Associated Pneumonia by Carbapenem Resistance Klebsiella","status":"COMPLETED","sponsor":"Tanta University","startDate":"2023-10-30","conditions":"Ventilator Associated Pneumonia ( VAP), Mechanical Ventilation","enrollment":70},{"nctId":"NCT04459052","phase":"PHASE2","title":"FDOPA PET and Nutritional Support in Parkinson's Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"Thomas Jefferson University","startDate":"2020-04-30","conditions":"Parkinson Disease, Idiopathic Parkinson Disease","enrollment":50},{"nctId":"NCT03241732","phase":"NA","title":"PET-MRI in Chronic Traumatic Brain Injury (CTBI)","status":"ENROLLING_BY_INVITATION","sponsor":"Thomas Jefferson University","startDate":"2017-06-07","conditions":"Chronic Traumatic Brain Injury","enrollment":150},{"nctId":"NCT05944458","phase":"PHASE4","title":"Efficacy of Intravenous N-Acetylcysteine in Preventing Linezolid-Induced Thrombocytopenia in Critically Ill Patients","status":"COMPLETED","sponsor":"Helwan University","startDate":"2023-08-01","conditions":"Linezolid, Antioxidant, Thrombocytopenia","enrollment":250},{"nctId":"NCT02750319","phase":"PHASE3","title":"Amiodarone and N-Acetylcysteine or Amiodarone Alone for Preventing Atrial Fibrillation After Thoracic Surgery","status":"ACTIVE_NOT_RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2016-04","conditions":"Thoracic Surgery, Atrial Fibrillation in High Risk Patients","enrollment":184},{"nctId":"NCT02569957","phase":"PHASE2","title":"Effect of Acetylcysteine With Topotecan Hydrochloride on the Tumor Microenvironment in Patients With Persistent or Recurrent High Grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer","status":"TERMINATED","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University","startDate":"2015-10-02","conditions":"Malignant Ovarian Endometrioid Tumor, Malignant Ovarian Serous Tumor, Recurrent Fallopian Tube Carcinoma","enrollment":1},{"nctId":"NCT01878695","phase":"PHASE1","title":"Pilot Study of Anti-oxidant Supplementation With N-Acetyl Cysteine in Stage 0/I Breast Cancer","status":"COMPLETED","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University","startDate":"2012-07-26","conditions":"Stage 0/1 Breast Cancer, Post Biopsy, Pre-surgery","enrollment":13},{"nctId":"NCT00585559","phase":"PHASE3","title":"Acetaminophen in aSAH to Inhibit Lipid Peroxidation and Cerebral Vasospasm","status":"TERMINATED","sponsor":"Vanderbilt University Medical Center","startDate":"2007-04","conditions":"Aneurysmal Subarachnoid Hemorrhage, Cerebral Vasospasm","enrollment":44},{"nctId":"NCT06811675","phase":"PHASE4","title":"The Efficacy of Dexamethasone in Combination With N-acetylcysteine in Preventing Neurocognitive Sequelae Due to Carbon Monoxide Poisoning","status":"RECRUITING","sponsor":"China Medical University Hospital","startDate":"2025-03-23","conditions":"Carbon Monoxide Poisoning, Delayed Neurocognitive Sequelae","enrollment":128},{"nctId":"NCT00780962","phase":"PHASE2","title":"N-Acetylcysteine to Prevent Radiocontrast Nephropathy in Emergency Department Patients","status":"COMPLETED","sponsor":"Beth Israel Deaconess Medical Center","startDate":"2007-10-16","conditions":"Radiocontrast Nephropathy","enrollment":399},{"nctId":"NCT00558142","phase":"PHASE4","title":"Mechanisms for the Effect of Acetylcysteine on Renal Function After Exposure to Radiographic Contrast Material","status":"COMPLETED","sponsor":"University of Edinburgh","startDate":"2008-02","conditions":"Radiocontrast-induced Nephropathy","enrollment":107},{"nctId":"NCT01209455","phase":"NA","title":"Mechanisms of N-acetylcysteine Mediated Vascular Adverse Effects","status":"COMPLETED","sponsor":"University of Edinburgh","startDate":"2011-01-03","conditions":"Poisoning","enrollment":24},{"nctId":"NCT06384833","phase":"PHASE4","title":"Combination of Vitamin C and N-Acetylcysteine to Improve Functional Outcome After Rotator Cuff Repair","status":"NOT_YET_RECRUITING","sponsor":"Mahidol University","startDate":"2024-05-01","conditions":"Rotator Cuff Tears","enrollment":110},{"nctId":"NCT03900988","phase":"PHASE3","title":"Intravenous N-acetylcysteine and Oseltamivir Versus Oseltamivir in Adults Hospitalized With Influenza and Pneumonia","status":"UNKNOWN","sponsor":"Chinese University of Hong Kong","startDate":"2023-05-08","conditions":"Influenza","enrollment":160},{"nctId":"NCT04226456","phase":"PHASE4","title":"Intratympanic Administration of N-acetylcysteine for Protection of Cisplatin-induced Ototoxicity","status":"TERMINATED","sponsor":"Centre Hospitalier Universitaire Saint Pierre","startDate":"2021-07-10","conditions":"Ototoxic Hearing Loss, Ototoxic Hearing Loss, Bilateral, Ototoxicity","enrollment":19},{"nctId":"NCT01465542","phase":"","title":"Treatment of APAP Toxicity With IV and Oral NAC 2008-2011","status":"COMPLETED","sponsor":"Akron Children's Hospital","startDate":"2011-06","conditions":"Acetaminophen Toxicity","enrollment":47},{"nctId":"NCT05927259","phase":"EARLY_PHASE1","title":"The Role of N-acetylcysteine as a Novel Adjuvant Treatment in Acute Organophosphorus Pesticide Poisoning","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2022-01-01","conditions":"Acute Organophosphorus Poisoned Patients","enrollment":40},{"nctId":"NCT00736541","phase":"NA","title":"N-acetylcysteine in Liver Transplantation","status":"COMPLETED","sponsor":"Ibtesam Hilmi","startDate":"2004-07","conditions":"End Stage Liver Failure","enrollment":100},{"nctId":"NCT04458298","phase":"PHASE2","title":"A Study to Evaluate OP-101 (Dendrimer N-acetyl-cysteine) in Severe Coronavirus Disease 2019 (COVID-19) Patients","status":"TERMINATED","sponsor":"Ashvattha Therapeutics, Inc.","startDate":"2020-08-11","conditions":"COVID-19","enrollment":28},{"nctId":"NCT05504655","phase":"","title":"N-Acetylcysteine as an Adjuvant Therapy in Critically Ill COVID-19 Patients:","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2022-09-01","conditions":"COVID-19 Pneumonia","enrollment":80},{"nctId":"NCT05555511","phase":"NA","title":"Perioperative Use of NAC to Prevent AKI in Patients With Pre-existing Moderate Renal Insufficiency Following Cardiac Surgery","status":"UNKNOWN","sponsor":"Ain Shams University","startDate":"2022-08-26","conditions":"Kidney Injury, Acute","enrollment":46},{"nctId":"NCT02470468","phase":"PHASE1, PHASE2","title":"Evaluation of Safety and Efficacy of DCVAC/LuCa (Immunotherapy of Lung Cancer) in Patients With Metastatic Lung Cancer","status":"COMPLETED","sponsor":"SOTIO a.s.","startDate":"2014-12","conditions":"Stage IV Non-small Cell Lung Cancer","enrollment":105},{"nctId":"NCT05264584","phase":"NA","title":"Renoprotective Effect of Febuxostat on Contrast Induced Acute Kidney Injury in Chronic Kidney Disease Patients Stage 3","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2020-12-01","conditions":"Chronic Kidney Disease stage3, Contrast-induced Nephropathy","enrollment":120},{"nctId":"NCT05089981","phase":"NA","title":"Intravenous NAC Use in ACLF Patients","status":"UNKNOWN","sponsor":"Aga Khan University","startDate":"2021-11-01","conditions":"Acute on Chronic Liver Failure(ACLF)","enrollment":100},{"nctId":"NCT04643821","phase":"EARLY_PHASE1","title":"NVD in Hypothermic HIE Neonates","status":"COMPLETED","sponsor":"Medical University of South Carolina","startDate":"2015-01-01","conditions":"HIE - Perinatal Hypoxic - Ischemic Encephalopathy","enrollment":30},{"nctId":"NCT04509258","phase":"PHASE4","title":"Effectiveness of N-acetyl Cysteine, Acetyl L- Carnitine and Medicated Paraffin Oil in Aluminium Phosphide Poisoning","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2020-10","conditions":"the Study Focus to Improve the Standard of Care Used for Aluminuim Phosphide Poisoning and to Save Patients With the Minimal Organ Damage","enrollment":100},{"nctId":"NCT04455243","phase":"PHASE3","title":"Inflammatory Regulation Effect of NAC on COVID-19 Treatment","status":"UNKNOWN","sponsor":"Dr. Tariq Alhawassi","startDate":"2020-08-01","conditions":"COVID-19","enrollment":1180},{"nctId":"NCT01800526","phase":"PHASE1, PHASE2","title":"A Pilot Study of N-acetylcysteine in Patients With Sickle Cell Disease","status":"COMPLETED","sponsor":"Bloodworks","startDate":"2013-03","conditions":"Sickle Cell Disease, Sickle Cell Anemia","enrollment":21},{"nctId":"NCT04368598","phase":"PHASE2","title":"The Combination of High-dose Dexamethasone and Acetylcysteine as the Treatment of Newly-diagnosed ITP","status":"UNKNOWN","sponsor":"Peking University People's Hospital","startDate":"2019-04-01","conditions":"Immune Thrombocytopenia","enrollment":44},{"nctId":"NCT03492047","phase":"PHASE1, PHASE2","title":"N-acetyl Cysteine Effect in Peripheral Neuropathy in Cancer Patients","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2018-04-01","conditions":"Peripheral Neuropathy Due to Chemotherapy","enrollment":75},{"nctId":"NCT01907061","phase":"NA","title":"Acute Renal Failure Post Liver Transplantation","status":"COMPLETED","sponsor":"Baylor Research Institute","startDate":"2007-07","conditions":"Acute Renal Failure","enrollment":30},{"nctId":"NCT02206152","phase":"PHASE1, PHASE2","title":"A Randomized Double Blinded Study to Examine the Use of N-acetyl Cysteine for the Prevention and Treatment of HAAF in Patients With Type 1 Diabetes","status":"COMPLETED","sponsor":"University of Minnesota","startDate":"2015-02","conditions":"Type 1 Diabetes, Hypoglycemia Unawareness","enrollment":22},{"nctId":"NCT00575419","phase":"PHASE1","title":"Safety Study Of N-Acetylcysteine For Prevention Of Contrast Induced Nephropathy In Patients w/Stage 3 Renal Failure","status":"TERMINATED","sponsor":"Oregon Health and Science University","startDate":"2007-11","conditions":"Contrast Induced Nephropathy","enrollment":6},{"nctId":"NCT02182167","phase":"PHASE2, PHASE3","title":"A Trial Of Intravenous N-Acetylcysteine In The Management Of Antituberculous Drug-Induced Hepatitis","status":"COMPLETED","sponsor":"University of Cape Town","startDate":"2014-05","conditions":"Drug-Induced Liver Injury","enrollment":102},{"nctId":"NCT00397735","phase":"PHASE1, PHASE2","title":"N-acetylcysteine in Intra-amniotic Infection/Inflammation","status":"COMPLETED","sponsor":"Ohio State University","startDate":"2006-10-01","conditions":"Labor, Premature, Preterm Premature Rupture of the Membranes, Infection","enrollment":68},{"nctId":"NCT03589495","phase":"PHASE4","title":"Safety and Efficacy of Adding Intravenous N-acetyl Cysteine in Colon Surgeries","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2015-07-30","conditions":"Systemic Inflammatory Response Syndrome","enrollment":60},{"nctId":"NCT02686385","phase":"NA","title":"Efficacy of N-acetylcysteine With or Without Steroids in Drug Induced Liver Injury","status":"TERMINATED","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2016-03-01","conditions":"Drug Induced Liver Injury","enrollment":4},{"nctId":"NCT02476526","phase":"PHASE4","title":"Safety of Low Dose IV Contrast CT Scanning in Chronic Kidney Disease","status":"COMPLETED","sponsor":"VA Greater Los Angeles Healthcare System","startDate":"2008-09","conditions":"Chronic Kidney Disease, Pulmonary Embolism, Renal Artery Stenosis","enrollment":50},{"nctId":"NCT01808521","phase":"EARLY_PHASE1","title":"A Pilot Study of N-acetylcysteine in Thrombotic Thrombocytopenia Purpura","status":"COMPLETED","sponsor":"Bloodworks","startDate":"2013-05","conditions":"Purpura, Thrombotic Thrombocytopenic, TTP","enrollment":3},{"nctId":"NCT01138137","phase":"PHASE1","title":"N-acetylcysteine Given IV With Cisplatin and Paclitaxel in Patients With Ovarian Cancer","status":"WITHDRAWN","sponsor":"OHSU Knight Cancer Institute","startDate":"2010-06","conditions":"Ovarian Carcinoma, Stage 3 or 4, Epithelial Ovarian Carcinoma, Primary Peritoneal Carcinoma","enrollment":""},{"nctId":"NCT00889538","phase":"NA","title":"Study of Glutathione, Vitamin C and Cysteine in Children With Autism and Severe Behavior Problems","status":"COMPLETED","sponsor":"University of Louisville","startDate":"2009-04","conditions":"Autism, Severe Behavior Disorder","enrollment":24},{"nctId":"NCT02761577","phase":"PHASE4","title":"A Prospective Study on Incidence and Prevention of Contrast-induced Nephropathy in Croatia","status":"COMPLETED","sponsor":"Clinical Hospital Centre Zagreb","startDate":"2012-06","conditions":"Kidney Diseases, Contrast Media Reaction","enrollment":90},{"nctId":"NCT02088502","phase":"PHASE2, PHASE3","title":"Theophylline, N-acetylcysteine, and Theophylline Plus N-acetylcysteine in Preventing Contrast-induced Nephropathy","status":"UNKNOWN","sponsor":"Isfahan University of Medical Sciences","startDate":"2013-09","conditions":"Contrast-Induced Nephropathy","enrollment":96},{"nctId":"NCT01050270","phase":"PHASE4","title":"Scottish and Newcastle Anti-emetic Pre-treatment for Paracetamol Poisoning Study (SNAP)","status":"COMPLETED","sponsor":"University of Edinburgh","startDate":"2010-09","conditions":"Overdose","enrollment":222},{"nctId":"NCT00003346","phase":"PHASE2","title":"Combination Chemotherapy in Treating Patients With Stage III or Stage IV Melanoma","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"1997-11","conditions":"Melanoma (Skin)","enrollment":80},{"nctId":"NCT00377403","phase":"PHASE4","title":"Treatment of Acute Sinusitis","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2006-10","conditions":"Acute Respiratory Infections, Acute Rhinosinusitis","enrollment":172},{"nctId":"NCT01578395","phase":"PHASE2","title":"Impact of Antioxidant Agents on the Number of DNA Double-strand Breaks After Radiation-based Cardiac Examinations","status":"COMPLETED","sponsor":"University of Zurich","startDate":"2012-04","conditions":"Focus of the Study: DNA Damage Due to Medical Diagnostic X-ray","enrollment":102},{"nctId":"NCT01612013","phase":"NA","title":"Intravenous High Dose NAC and Sodium Bicarbonate for the Prevention of Contrast-induced Acute Injury","status":"COMPLETED","sponsor":"Federal University of São Paulo","startDate":"2005-05","conditions":"Acute Renal Failure","enrollment":500},{"nctId":"NCT00374088","phase":"PHASE2","title":"N-Acetylcysteine in Neonatal Congenital Heart Surgery (INACT Study)","status":"COMPLETED","sponsor":"University of Michigan","startDate":"2005-02","conditions":"Transposition of Great Vessels, Congenital Heart Disease","enrollment":21},{"nctId":"NCT00725179","phase":"","title":"Treatment of Acetaminophen Toxicity With N-acetylcysteine","status":"COMPLETED","sponsor":"Akron Children's Hospital","startDate":"2008-08","conditions":"Acetaminophen Toxicity","enrollment":130},{"nctId":"NCT01359722","phase":"NA","title":"N-acetylcysteine to Prevent Renal Failure","status":"UNKNOWN","sponsor":"Instituto do Coracao","startDate":"2010-03","conditions":"Kidney Failure, Acute, Oxidative Stress Induction","enrollment":50},{"nctId":"NCT00188630","phase":"PHASE3","title":"N-Acetylcysteine for Preventing Renal Injury After Cardiac Surgery","status":"COMPLETED","sponsor":"University Health Network, Toronto","startDate":"2003-07","conditions":"Heart Disease, Acute Renal Failure","enrollment":176},{"nctId":"NCT01138956","phase":"NA","title":"Immune Response of Visceral Leishmaniasis PatientsTreated With Antimonial Plus N-Acetylcysteine","status":"UNKNOWN","sponsor":"Hospital Universitário Professor Edgard Santos","startDate":"2010-04","conditions":"Visceral Leishmaniasis, Immune Response, Treatment","enrollment":40},{"nctId":"NCT01017796","phase":"EARLY_PHASE1","title":"Contrast Agent-associated Nephrotoxicity in Intensive Care Unit Patients","status":"UNKNOWN","sponsor":"University of Thessaly","startDate":"2009-01","conditions":"Contrast Induced Nephropathy","enrollment":100},{"nctId":"NCT00830193","phase":"PHASE2, PHASE3","title":"N-Acetylcysteine in Critically Ill Patients Undergoing Contrast Enhanced Computed Tomography","status":"COMPLETED","sponsor":"Unity Health Toronto","startDate":"2002-08","conditions":"Contrast Induced Nephropathy, Critically Ill","enrollment":45}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":41,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["NAC"],"phase":"phase_3","status":"active","brandName":"IV N-acetylcysteine","genericName":"IV N-acetylcysteine","companyName":"Medical University of South Carolina","companyId":"medical-university-of-south-carolina","modality":"Small molecule","firstApprovalDate":"","aiSummary":"IV N-acetylcysteine replenishes intracellular glutathione and acts as a free radical scavenger to reduce oxidative stress and inflammation. Used for Acetaminophen (paracetamol) overdose, Acute respiratory distress syndrome (ARDS), Chronic obstructive pulmonary disease (COPD) exacerbations.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}